PMID- 24199847 OWN - NLM STAT- MEDLINE DCOM- 20141112 LR - 20220321 IS - 1873-6823 (Electronic) IS - 0741-8329 (Print) IS - 0741-8329 (Linking) VI - 47 IP - 8 DP - 2013 Dec TI - Toll-like receptor 4 (Tlr4) knockout rats produced by transcriptional activator-like effector nuclease (TALEN)-mediated gene inactivation. PG - 595-9 LID - S0741-8329(13)00160-2 [pii] LID - 10.1016/j.alcohol.2013.09.043 [doi] AB - Genetically engineered mice are a valuable resource for studies of the behavioral effects of ethanol. However, for some behavioral tests of ethanol action, the rat is a superior model organism. Production of genetically engineered rats has been severely hampered due to technical limitations. Here we utilized a promising new technique for efficient site-specific gene modification to create a novel gene knockout rat line. This approach is based on transcriptional activator-like effector nucleases (TALENs). TALENs function in pairs and bind DNA in a sequence-specific manner. Upon binding to the target sequence, a functional nuclease is reconstituted that creates double-stranded breaks in the DNA that are efficiently repaired by non-homologous end joining. This error-prone process often results in deletions of varying lengths at the targeted locus. The toll-like receptor 4 (Tlr4) gene was selected for TALEN-mediated gene inactivation. Tlr4 has been implicated in ethanol-induced neuroinflammation and neurodegeneration, as well as multiple ethanol-induced behavioral effects. To generate Tlr4 knockout rats, a pair of TALEN constructs was created that specifically target Exon 1 immediately downstream of the start of translation. TALEN mRNAs were microinjected into the cytoplasm of one-cell Wistar rat embryos. Of 13 live-born pups that resulted, one harbored a mutation in Exon 1 of Tlr4. The mutated allele consisted of a 13 base-pair deletion that was predicted to create a frameshift mutation after amino acid 25. This founder rat successfully transmitted the mutation to F1 offspring. Heterozygous F1 offspring were interbred to produce homozygous F2 animals. Homozygous mutants expressed the 13-bp deletion in Tlr4 mRNA. In contrast to control rats that produced a robust increase in plasma tumor necrosis factor alpha in response to a lipopolysaccharide challenge, homozygous rats had a markedly attenuated response. Thus, the mutant Tlr4 allele generated by TALEN-mediated gene inactivation represents a null allele. This knockout rat line will be valuable for studies of ethanol action as well as more general inflammatory conditions including septic shock. In conclusion, TALEN-mediated gene targeting in rat zygotes represents an inexpensive, efficient, and rapid method for creating genetically engineered rats. CI - Copyright (c) 2013 Elsevier Inc. All rights reserved. FAU - Ferguson, Carolyn AU - Ferguson C AD - University of Pittsburgh, Department of Anesthesiology, 6060 Biomedical Science Tower-3, 3501 Fifth Avenue, Pittsburgh, PA 15261, USA. FAU - McKay, Matthew AU - McKay M FAU - Harris, R Adron AU - Harris RA FAU - Homanics, Gregg E AU - Homanics GE LA - eng GR - U01 AA020889/AA/NIAAA NIH HHS/United States GR - AA020889/AA/NIAAA NIH HHS/United States PT - Journal Article PT - Research Support, N.I.H., Extramural DEP - 20131011 PL - United States TA - Alcohol JT - Alcohol (Fayetteville, N.Y.) JID - 8502311 RN - 0 (Lipopolysaccharides) RN - 0 (RNA, Messenger) RN - 0 (Toll-Like Receptor 4) RN - 0 (Tumor Necrosis Factor-alpha) RN - EC 3.1.- (Deoxyribonucleases) SB - IM MH - Alleles MH - Animals MH - Deoxyribonucleases/*metabolism MH - Exons MH - Female MH - Gene Knockout Techniques/*methods MH - *Gene Silencing MH - Homozygote MH - Lipopolysaccharides/pharmacology MH - Male MH - Mutation/genetics MH - RNA, Messenger/genetics MH - Rats MH - Toll-Like Receptor 4/*deficiency/genetics MH - Tumor Necrosis Factor-alpha/blood PMC - PMC3844088 MID - NIHMS531920 OTO - NOTNLM OT - Gene targeted rats OT - Genome editing OT - Knockout rats OT - Toll-like receptor 4 (Tlr4) OT - Transcriptional activator-like effector nuclease (TALEN) EDAT- 2013/11/10 06:00 MHDA- 2014/11/13 06:00 PMCR- 2014/12/01 CRDT- 2013/11/09 06:00 PHST- 2013/08/22 00:00 [received] PHST- 2013/09/27 00:00 [revised] PHST- 2013/09/28 00:00 [accepted] PHST- 2013/11/09 06:00 [entrez] PHST- 2013/11/10 06:00 [pubmed] PHST- 2014/11/13 06:00 [medline] PHST- 2014/12/01 00:00 [pmc-release] AID - S0741-8329(13)00160-2 [pii] AID - 10.1016/j.alcohol.2013.09.043 [doi] PST - ppublish SO - Alcohol. 2013 Dec;47(8):595-9. doi: 10.1016/j.alcohol.2013.09.043. Epub 2013 Oct 11.